BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12193602)

  • 21. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase beta.
    Lund IK; Andersen HS; Iversen LF; Olsen OH; Møller KB; Pedersen AK; Ge Y; Holsworth DD; Newman MJ; Axe FU; Møller NP
    J Biol Chem; 2004 Jun; 279(23):24226-35. PubMed ID: 15024017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B.
    Iversen LF; Andersen HS; Branner S; Mortensen SB; Peters GH; Norris K; Olsen OH; Jeppesen CB; Lundt BF; Ripka W; Møller KB; Møller NP
    J Biol Chem; 2000 Apr; 275(14):10300-7. PubMed ID: 10744717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
    Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
    Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases.
    McCain DF; Wu L; Nickel P; Kassack MU; Kreimeyer A; Gagliardi A; Collins DC; Zhang ZY
    J Biol Chem; 2004 Apr; 279(15):14713-25. PubMed ID: 14734566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
    Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
    Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular details of WPD-loop movement differ in the protein-tyrosine phosphatases YopH and PTP1B.
    Brandão TA; Johnson SJ; Hengge AC
    Arch Biochem Biophys; 2012 Sep; 525(1):53-9. PubMed ID: 22698963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residue 182 influences the second step of protein-tyrosine phosphatase-mediated catalysis.
    Pedersen AK; Guo XL; Møller KB; Peters GH; Andersen HS; Kastrup JS; Mortensen SB; Iversen LF; Zhang ZY; Møller NP
    Biochem J; 2004 Mar; 378(Pt 2):421-33. PubMed ID: 14572311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors.
    Wang XY; Bergdahl K; Heijbel A; Liljebris C; Bleasdale JE
    Mol Cell Endocrinol; 2001 Feb; 173(1-2):109-20. PubMed ID: 11223182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residue 259 is a key determinant of substrate specificity of protein-tyrosine phosphatases 1B and alpha.
    Peters GH; Iversen LF; Branner S; Andersen HS; Mortensen SB; Olsen OH; Moller KB; Moller NP
    J Biol Chem; 2000 Jun; 275(24):18201-9. PubMed ID: 10748206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covalent inhibition of protein tyrosine phosphatases.
    Ruddraraju KV; Zhang ZY
    Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis.
    Adams J; Thornton BP; Tabernero L
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serendipitous discovery of light-induced (In Situ) formation of an Azo-bridged dimeric sulfonated naphthol as a potent PTP1B inhibitor.
    Bongard RD; Lepley M; Thakur K; Talipov MR; Nayak J; Lipinski RAJ; Bohl C; Sweeney N; Ramchandran R; Rathore R; Sem DS
    BMC Biochem; 2017 May; 18(1):10. PubMed ID: 28569147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein tyrosine phosphatases: strategies for distinguishing proteins in a family containing multiple drug targets and anti-targets.
    Hoffman BT; Nelson MR; Burdick K; Baxter SM
    Curr Pharm Des; 2004; 10(10):1161-81. PubMed ID: 15078147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
    Schmidt MF; Groves MR; Rademann J
    Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphatase.
    Asante-Appiah E; Patel S; Desponts C; Taylor JM; Lau C; Dufresne C; Therien M; Friesen R; Becker JW; Leblanc Y; Kennedy BP; Scapin G
    J Biol Chem; 2006 Mar; 281(12):8010-5. PubMed ID: 16407290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activity.
    Liljebris C; Larsen SD; Ogg D; Palazuk BJ; Bleasdale JE
    J Med Chem; 2002 Apr; 45(9):1785-98. PubMed ID: 11960490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.
    Puius YA; Zhao Y; Sullivan M; Lawrence DS; Almo SC; Zhang ZY
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13420-5. PubMed ID: 9391040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.